by Dr. Reinhard Hiller | Aug 28, 2018 | Announcement
To stimulate Genomics research, Illumina has created, and successfully run, a core lab program in many countries around the world. The Centre for Proteomic & Genomic Research (CPGR), and Whitehead Scientific, distributor for Illumina in South Africa, are bringing...
by Dr. Reinhard Hiller | Apr 5, 2018 | Blog
Context CPGR has implemented and provided Precision Medicine solutions over the last two years to the South African health care market. In doing so, it has encountered challenges and opportunities. We believe that these can be addressed by creating an integrated...
by Dr. Reinhard Hiller | Jan 2, 2018 | Blog
In 2017, we took concrete steps into the Precision Medicine field in South Africa. I am saying this with some caution, for two reasons: firstly, Precision Medicine is an ambiguous term that means different things to different people; secondly, it’s one thing to talk...
by Dr. Reinhard Hiller | Sep 22, 2014 | Blog, Emerging markets, Innovation management, The "Omics" Revolution
Yes! If a set of other components is in place to make a complex innovation equation work… Introduction Genomics holds great promises for drug development through the identification of new drug targets, better understanding of disease mechanism, and the elucidation of...
by Dr. Reinhard Hiller | Sep 19, 2014 | Blog, Emerging markets, The "Omics" Revolution
My short answer to this is, yes, but the real value of Genomics goes beyond an economic return and cannot be captured easily in dollars and cents! Background According to US-based non-profit research organisation Battelle, the Human Genome Project (HGP) contributed...
Recent Comments